BJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

British Journal of Radiology (2006) 79, 24-31
© 2006 British Institute of Radiology
doi: 10.1259/bjr/81790390

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jones, B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jones, B

President's conference papers

The case for particle therapy

B Jones, MD, FRCR, MedFIPEM

Queen Elizabeth University Hospital, Birmingham B15 2TH, UK

Among the most important decisions facing the British Government regarding the treatment of cancer in the National Health Service (NHS) is the purchase of charged particle therapy (CPT) centres. CPT is different from conventional radiotherapy: the dose is deposited far more selectively in Bragg Peaks by either protons or "heavy" ions, such as carbon. In this way, it is possible to "dose paint" targets, voxel by voxel, with far less dose to surrounding tissues than with X-ray techniques. At present the UK possesses a 62 MeV cyclotron proton facility at Clatterbridge (Wirral), which provides therapy for intraocular cancers such as melanoma; for deeper situated cancers in the pelvis, chest etc., much higher energies, over 200 MeV are required from a synchrotron facility. There is an impressive expansion in particle beam therapy (PBT) centres worldwide, since they offer good prospects of improved quality of life with enhanced cancer cures in situations where conventional therapy is limited due to radioresistance or by the close proximity of critical normal tissues. There is a threat to UK Oncology, since it is anticipated that several thousand British patients may require referral abroad for therapy; this would severely disrupt their multidisciplinary management and require demanding logistical support.




This article has been cited by other articles:


Home page
Br. J. Radiol.Home page
B JONES
Joint symposium 2009 on carbon ion radiotherapy
Br. J. Radiol., November 1, 2009; 82(983): 884 - 889.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
BJR review of the year - 2006
Br. J. Radiol., March 1, 2007; 80(951): 147 - 151.
[Full Text] [PDF]


Home page
Br. J. Radiol.Home page
A J Munro
Particle matters.
Br. J. Radiol., April 1, 2006; 79(940): 276 - 277.
[Full Text] [PDF]


Home page
Br. J. Radiol.Home page
B Jones
HCPBM [Heavy Charged Particles in Biology & Medicine] and ENLIGHT [European Network for Light Ions] Meetings, Oropa (Italy), June 2005.
Br. J. Radiol., April 1, 2006; 79(940): 278 - 284.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
BJR DMFR IMAGING  ALL BIR JOURNALS 
Copyright © 2006 by the British Institute of Radiology.